25.11.2016 • News

Barentz Takes Majority of Globe Ingredients

(c) Barentz
(c) Barentz

Dutch distributor Barentz has taken a majority stake in Globe Ingredients, an international trader and distributor of feed, food and pharmaceutical ingredients. The deal strengthens Barentz’ position as an animal nutrition provider and extends its business into new geographies. The size of the stake and financial terms were not disclosed. Globe Ingredients, known as Globe Fine Chemicals until 2016, is headquartered in Zwijndrecht, the Netherlands, with offices in Serbia, China and Colombia. Its core business is supplying vitamins and amino acids for the feed industry.

Hidde van der Wal, CEO of Barentz International, said the acquisition fits perfectly with its business plan toward 2025 in which it aims to acquire strategic companies that also expand its geographic reach. The two directors of Globe Ingredients  –  Martijn Krijgsman and Frank van Eeden – will continue to manage the company. “Globe Ingredients will benefit from the distribution network and expertise of Barentz while at the same time Barentz can spread its business worldwide in the sales and distribution of feed additives,” said van Eeden.

Barentz has made several acquisitions in the past two years, including US-based AmTech Ingredients, China’s New Skyport and Indonesia’s Astabumi in 2015. Its most recent venture was in February this year when it set up Barentz Middle East in partnership with Iranian trading firm Future Way Holding.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.